Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID-19 pandemic

被引:3
|
作者
Qiao, Tingting [1 ]
Gao, Dingwei [1 ]
Tong, Junyu [1 ]
Shen, Yun [1 ]
Ma, Jiayue [1 ]
Lv, Zhongwei [1 ]
Li, Dan [2 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nucl Med, Sch Med, Shanghai, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Nucl Med, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Differentiated thyroid cancer; Radioactive iodine therapy; Anxiety; Depression; COVID-19; QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL DISTRESS; RADIOTHERAPY; HEALTH; HEAD;
D O I
10.1007/s00520-022-07422-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objection The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence and risk factors for anxiety and depression in thyroid cancer patients prior to RAI therapy. Methods Clinical data were collected from patients with differentiated thyroid cancer (DTC) patients preparing for RAI therapy. Anxiety and depression were measured before RAI therapy using the Generalized Anxiety Disorder Questionnaire (GAD-7) and Patient Health Questionnaire (PHQ-9). We used the chi-square test and logistic regression analysis to identify independent risk factors for anxiety and depression. Results A total of 112 patients with thyroid cancer were included. Of these, 72.32% ( n = 81) were female, with a mean age of 41.50 years. Anxiety and depression were reported by 46 (41.08%) and 38 (33.93%) patients, respectively. Based on the chi-square test and univariate logistic regression analysis, being female and having ever-experienced RAI therapy were significant risk factors for anxiety and depression among DTCs prior to RAI therapy. On multivariable analysis, the results of model 2 which included age, sex, education level, and ever suffering radioactive iodine therapy showed that being female was markedly associated with anxiety and depression in these patients, while having ever undergone RAI therapy was significantly related to anxiety but not depression. Conclusions The incidence of anxiety and depression among patients with DTC prior to RAI therapy were 41.08% and 33.93%, respectively. Being female and having ever experienced RAI therapy significantly influenced anxiety and depression. Based on these findings, anxiety and depression assessment should be an important part of pre-RAI therapy in patients with DTC, and appropriate psychological nursing intervention can be carried out for key patients.
引用
收藏
页码:10169 / 10177
页数:9
相关论文
共 50 条
  • [1] Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
    Tingting Qiao
    Dingwei Gao
    Junyu Tong
    Yun Shen
    Jiayue Ma
    Zhongwei Lv
    Dan Li
    Supportive Care in Cancer, 2022, 30 : 10169 - 10177
  • [2] Assessment of anxiety/depression among cancer patients before and during the COVID-19 pandemic
    Adzrago, David
    Sulley, Saanie
    Tagoe, Ishmael
    Ormiston, Cameron K.
    Odame, Emmanuel A.
    Mamudu, Lohuwa
    Williams, Faustine
    PSYCHO-ONCOLOGY, 2022, 31 (10) : 1681 - 1691
  • [3] Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic
    Obispo-Portero, Berta
    Cruz-Castellanos, Patricia
    Jimenez-Fonseca, Paula
    Rogado, Jacobo
    Hernandez, Raquel
    Alfredo Castillo-Trujillo, Oscar
    Asensio-Martinez, Elena
    Gonzalez-Moya, Manuel
    Carmona-Bayonas, Alberto
    Calderon, Caterina
    SUPPORTIVE CARE IN CANCER, 2022, 30 (04) : 3363 - 3370
  • [4] Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic
    Berta Obispo-Portero
    Patricia Cruz-Castellanos
    Paula Jiménez-Fonseca
    Jacobo Rogado
    Raquel Hernandez
    Oscar Alfredo Castillo-Trujillo
    Elena Asensio-Martínez
    Manuel González-Moya
    Alberto Carmona-Bayonas
    Caterina Calderon
    Supportive Care in Cancer, 2022, 30 : 3363 - 3370
  • [5] Anxiety and depression in lung cancer patients during Covid-19 pandemic
    Jacob, Anitha
    Mogal, Rahul
    Barlow, Andrew
    Vancheeswaran, Rama
    LUNG CANCER, 2021, 156 : S16 - S16
  • [6] Depression, anxiety, & loneliness among cancer survivors during the COVID-19 pandemic
    White, Larissa Lee
    Goldberg, Shauna R.
    Feigelson, Heather Spencer
    Burnett-Hartman, Andrea N.
    JOURNAL OF PSYCHOSOCIAL ONCOLOGY, 2024, 42 (02) : 242 - 255
  • [7] ANXIETY AND DEPRESSION IN BREAST CANCER PATIENTS DURING COVID-19 PANDEMIC IN TUNISIA
    Berrazaga, Y.
    Rachdi, H.
    Mejri, N.
    Ferjaoui, M.
    Daoud, N.
    Boussen, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A96 - A96
  • [8] Depression and anxiety during COVID-19 pandemic
    Nicolini, Humberto
    CIRUGIA Y CIRUJANOS, 2020, 88 (05): : 542 - 547
  • [9] Anxiety and depression among medical students during COVID-19 pandemic
    Villalon Lopez, Francisco J.
    Moreno Cerda, Maria Ivonne
    Gonzalez Venegas, Williams
    Soto Amaro, Adrian Alonso
    Arancibia Campos, Javiera Valentina
    REVISTA MEDICA DE CHILE, 2022, 150 (08) : 1018 - 1025
  • [10] Anxiety and depression during the COVID-19 pandemic in newly diagnosed advanced cancer patients
    Obispo, B.
    Hernandez, R.
    Cruz, P.
    Fernandez Montes, A.
    Gil Raga, M.
    Garcia, O. A.
    Rogado, J.
    Asensio-Martinez, E.
    Piera Molons, N.
    Pacheco-Barcia, V.
    Lopez de Ceballos, M. H.
    Cano, J. M.
    Ostios Garcia, L.
    Antonanzas Basa, M.
    Lorente, D.
    Manzano Fernandez, A.
    Hernando Polo, S.
    Gonzalez Moya, M.
    Garcia, T.
    Calderon, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S1098 - S1098